title: Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key?
authors.forename: Gerald
authors.initials: G
authors.lastname: Willimsky
authors.forename: Ulrike
authors.initials: U
authors.lastname: Protzer
authors.forename: Percy
authors.initials: P
authors.lastname: Knolle
authors.forename: Mathias
authors.initials: M
authors.lastname: Heikenwalder
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology* / Q000637:transplantation; D059016:Tumor Microenvironment
references.citation: J Clin Oncol. 2011 Mar 1;29(7):917-24
references.pmid: 21282551
references.citation: Cancer Cell. 2013 Apr 15;23(4):516-26
references.pmid: 23597565
references.citation: Nat Immunol. 2013 Jun;14(6):574-83
references.pmid: 23584070
references.citation: Immunity. 2013 Jan 24;38(1):140-52
references.pmid: 23260194
references.citation: J Clin Invest. 2013 Mar;123(3):1032-43
references.pmid: 23454765
references.citation: N Engl J Med. 2011 Aug 25;365(8):725-33
references.pmid: 21830940
references.citation: Lancet. 2012 Mar 31;379(9822):1245-55
references.pmid: 22353262